These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Statins: Are they really all the same? Cortese F. Curr Vasc Pharmacol; 2019 Oct; 17(3):211-212. PubMed ID: 30003860 [No Abstract] [Full Text] [Related]
3. MY APPROACH to the Patient With Memory Loss Who Needs a Statin. Watson KE, Sallam T. Trends Cardiovasc Med; 2017 Feb; 27(2):158-159. PubMed ID: 28107839 [No Abstract] [Full Text] [Related]
4. Strategies to Overcome Residual Risk During Statins Era. Cho KI, Yu J, Hayashi T, Han SH, Koh KK. Circ J; 2019 Sep 25; 83(10):1973-1979. PubMed ID: 31391351 [Abstract] [Full Text] [Related]
5. Editorial commentary: The long and winding road to follow dyslipidemia guidelines. Bonaventura A. Trends Cardiovasc Med; 2024 Aug 25; 34(6):379-380. PubMed ID: 37673292 [No Abstract] [Full Text] [Related]
6. Nonadherence to statins: individualized intervention strategies outside the pill box. Lansberg P, Lee A, Lee ZV, Subramaniam K, Setia S. Vasc Health Risk Manag; 2018 Aug 25; 14():91-102. PubMed ID: 29872306 [Abstract] [Full Text] [Related]
7. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey. Burstein B, Altobelli KK, Williams K, Cannon CP, Pencina MJ, Sniderman AD, Thanassoulis G. Circulation; 2017 Nov 07; 136(19):1860-1862. PubMed ID: 29109198 [No Abstract] [Full Text] [Related]
8. Clinician Decision Support Tools: Advances in Lipid-Lowering Treatment Intensification. Marvel FA, Grant JK, Martin SS. Circ Cardiovasc Qual Outcomes; 2024 May 07; 17(5):e010884. PubMed ID: 38634283 [No Abstract] [Full Text] [Related]
10. Possible effect of statins on serum vitamin D levels in patients with chronic renal disease. Mazhar F. Saudi J Kidney Dis Transpl; 2017 May 07; 28(2):428-429. PubMed ID: 28352033 [No Abstract] [Full Text] [Related]
11. Routine CAC-scoring prior to initiation of statin therapy - a European perspective. Mahabadi AA, Nasir K, Rassaf T. Eur J Prev Cardiol; 2019 Sep 07; 26(14):1559-1561. PubMed ID: 30913900 [No Abstract] [Full Text] [Related]
12. The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality. Diprose W, Verster F. Circulation; 2016 Nov 22; 134(21):1599-1600. PubMed ID: 27881503 [No Abstract] [Full Text] [Related]
17. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED. J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801 [Abstract] [Full Text] [Related]
19. News from ESC congress 2019: New ESC/EAS guidelines for dyslipidaemia management published. Stock J. Atherosclerosis; 2019 Dec 08; 291():124-126. PubMed ID: 31668350 [No Abstract] [Full Text] [Related]
20. Emerging views of statin pleiotropy and cholesterol lowering. Yu D, Liao JK. Cardiovasc Res; 2022 Jan 29; 118(2):413-423. PubMed ID: 33533892 [Abstract] [Full Text] [Related] Page: [Next] [New Search]